pre-seed
Stage
1
Investors
About
Bexson Biomedical is a research-stage company developing a subcutaneous ketamine treatment platform for pain management and mental health disorders. Their lead product, BB106, utilizes a wearable infusion pump for precise dosing of ketamine.
Explore bexom biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.